µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º -{h
J H.K.C(
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ >k']T/%
^s\3/z>b4!
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) A5#y?Aq
XwM611
1. ICAM-1 4([.xT
8GJdRL(
2. interleukin 12(IL-12) /E wGW
"Clz'J]{
3. tumor infiltrating lymphocyte Dj-s5pAW
Np)3+!^1"
4. TCR/CD3 complex jdevat,&u
$#o1MX
5. hematopoietin receptor family vUQFQ
3l!NG=R
6. individual idiotype(IdI) T+"f]v
zIQzmvf
7. integrin 9T2xU3UyY
"
oy\_1|
8. colony-stimulatory factor (CSF) &UAe!{E
0
uMXc0fs!$
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© +2cs#i
fF?6j
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? w=r&?{
L3y5 a?G
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ ty1fcdFZM
T!q_/[i~7
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷ÓᣠSVP:D3)
)&NAs
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£ (4~WWU (iT
,-*iCs<
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) f~& a-
dK?);*w]
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£ _pDjg%A>n
K\=8eg93Z
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) oC dGQ7G}
=v2%Vs\7k
3. immunoglobulin superfamily (IgSF) ]Bu DaxWN
UKB_Yy^Y
4. selectin \d68-JS@~
MZm'npRf
5. anti-idiotypic antibody (¦ÁId) VK
.^v<Yo
Cyk s
6. major histocompatibility complex(MHC) bAhZ7;T~
n
E:'Zxj
7. immunotolerance tjzA)/T,4
K^D82tP
8. biological reponse modifier(BRM) R$0U<(/
[!+D<Y
9. immune reponse gene (Ir gene) d.}}s$Q
iz
x[
10. reshaped antibody (or reconstituted antibody) wa?+qiWnrl
E2:D(7(;l
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© <c%n?QK{
v5Y@O|i#
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ c
IZc:
K`+vfqX
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? p$OD*f_b
;/A}}B]y
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ O)<r>vqe}
pI^=B-7
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? &q>h*w
4O
'5WN,Vy8.
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ wO.B~`y
@^HwrwRA
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? fk\5D[j^
c%yh(g
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ BD4"pcr
p2a?9R
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ 0#
UAjT3
(\uAAW"
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? x 8M#t(hw
z (#Xca
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ B%(K0`G#X
|$ w0+bV*
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: r&/D~g\"|[
+DxifXtB
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: }{#7Z8
*
S{\#s
̉񧄤 KMe.i'
{V=vnL--
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© B~4mk
2}|vWKej{
1. CD8 K.r!?cfv
>]C<j4
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) h
bdEw=r?
@u<0_r
t
3. immunoglobulin fold(Ig fold) .0KOnLdK
@ikUM+A {
4. cadherin (Ca-dependent cell adhesion moleculers) {MA@A5
@b8X%0B7
5. idiotype-anti-idiotypic antibody immune network theory ^
Y#
@$c
|#!eMJ&0
6. HLA class II antigen US"2O!u
J~fuW?a]r
7. complementarity-determining region (CDR) 4h(jw
7d%A1}Bq$
8. perforin(or pore-forming protein ,PFP) z`;&bg\8
tc!!W9{69
9. high affinity IL-2 receptor vRq=m8
fc["
10. artificial active immunization ZKZl>dDuh
^7J~W'hI
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© c&0;wgieg
q+r `e
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦Óᣠ|;X?">7NW
ab8oMi`z
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 >Iu]T{QNO
TW'E99wG
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ ]Y?{$M
G
uEc0/a :.
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ h[Ndtq>3{
C.b,]7i
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ } IIK~d,
m~Kch~~]
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? @&!=m]D*
94Kuy@0:+
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ M63s(f
*u:;:W&5y
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ aYv'H
L:|X/c9r[
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ]Ct`4pA
c,3'wnui
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ xI.
Orpw
9 AQ96
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© N'lGA;}i
doxdRYKL
1. immunoglobulin gene rearrangement 1B9Fb.i
e]dPF[?7
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) m11"i=S"
"/ a*[_sV
3. flow cytometry(FCM) Z>>gXh<e[
FOlA* U4U
4. carrier effect Zh@4_Z9n!
6ywnyh
5. positive selection of T lymphocytes in thymus pAUfG^v
a `[?,W:q
6. mouse TH1(Th1) and TH2(Th2) subsets 6,V.j>z
m-Z'K_oQ
7. perforin (pore-forming protein ,PFP) U 3wsWSO
yPzULO4
8. ADCC(antibody-dependent cell-mediated cytotoxicity) FJn~
=hA
]sm0E@ 1
9. SH-2(src-homology region 2) Ul7pxzj
w>9H"Q[
10. Ab2¦Â (internal image) @2%VU#!m
mhJOR'2
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© kw}ISXz v
~'Qpf 8)
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? [#
tT o;q
NBbY## w0
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? S7#^u`'Q_^
hNR>Hy\
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦Óᣠ8^ ~ZNU-~v
-f|+
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ ^RFmRn
*`pec3"
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦Óᣠ}HA2ce\
aP6%OI
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) Vp{RX8?.
|+4E
8;4_
ÃâÒßѧרҵ£º [}xIg8
<g|nmu)o$
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ BB73'W8y
wHN`-
5
%
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? M'!!EQo
U}vtVvx
´«È¾²¡Ñ§×¨Òµ£º I;":O"ij\
1r-,VX7
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ :R|2z`b!
*i]Z=
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£ k9VQ6A
YWBP'Mo
Ïû»¯×¨Òµ£º 2QuypVC ]
s)7`r6w
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ 7zkm
$lG--s
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? >8mW-p
J`D<
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ va*>q-QCr
Hd@T8 D*A
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© $MVeMgPa
B xN#Nk~
1. Fas(CD95)/FasL ?Kz`
O>"6
FVLA^$5
c
2. common chain of cytokine receptor P9HPr2
P*^UU\x'4I
3 . TCR/CD3 complex %$-3fj7
f*H}eu3/j
4. negaive selection of thymocytes [(^''*7r+T
WAXrA$:3J
5. artificial active immune ).#D:eO[~
cngPc]?N
6. anti-idiotypic 7^}Z
%c
Tf]VcEF
7. IgSF sBG(CpQ
ZFw743G
8. Integrin f2K3*}P
'`VO@a
9. chemokine /]58:euR
{y%O_-C'r
10. B7/CD28 *m Tc4&*
UVRV7^eTe
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© IaqN@IlWb
.:Xe* Q
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ t-{OP?cE1
Z19y5?uR
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£ -BH'.9uqGQ
Wl"fh_
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ ;Awzm )Q
dKG<"
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£ a'.=.eDQ
SQCuY<mD
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ N^j''siB
)CU(~s|s
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ l1j
6/C
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© $O>MV
gKEvgXOj
1. B7/CD28 ?["ZEa
KW
kT
9[H
2. Th1 subset <AXYqH7%A
Lg53
Ms%
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© 7E]l=Z`x
*gKr1}M
4. antibody affinity maturation }jXUd=.Nu
Z ISd0hV
5. AP-1 %iML??S
&wvv5Vd
6. single chain variable fragment£¨ScFv£© w/@%xy
tt91)^GdYa
7. NK cell receptor vDL/PXNC
m]vr|:{6/
8. Zinkernagel-Doherty phenomenon my0->W%L
n*uZ=M_/Q
9. Ig fold C<)&qx3
pu#<qD*w
10. CD40/CD40L {,X(
fJ
%stktVDAP
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© 2y,wN"qH*
4
]R3*F
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£ bL%)k61G_v
`VbG%y&I
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
q\"$~*
HB^azHr
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ ];YOP%2
CaMG$X&O
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ pcG
q
X35hLp8 M
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ 5 Da(DA
04TV./uA
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ (@9-"W
#c_ZU\"h"
3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£ .#}R$}e+
:gn!3P}p?
Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£© ^EZoP:x(oE
jw)t"S/E
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© Qpc>5p![3
Mtlj I6
1.Co-stimulators (or co-stimulating molecules) `7`iCYiTy
.'M]cN~
2.NK-kB KAGq\7
9,IGZ55C
3.Immunoglobulin superfamily O B:G5B`
IN"qJ3<k
4.antigen-presenting cell (APC) (Y86q\DQ?|
<v?-$3YT
5.death domain r QF%;
q :gH`5N
6.CCR and CXCR !#QD;,SE+
G7u7x?E:B`
7.Lectin (or mitogen) ouujd~b+
aE+E'iL
8.Clusters of differentiation, CD)
hM-qC|!
z
'j%.Dd8
9.B7 family V'8
(}(s/
k~R_Pq
S
10.Cytotoxic T lymphocyte, CTL) 5}f$O
kC)dia{$
11.IL-15 and IL-15 receptor (IL-15R) *<KY^;
8I*fPf
12.MHC restriction ]>!]X*\9
mR@iGl\\
13.Affinity-chromatography NWFZ:h@v
>[[< 5$,T
14.Cyctosprin A, CsA
wI)W:mUZZ
=fm/l-P@
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) Da.v yp
tP`,Egf"g
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© UJO+7h'
k(et b#
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 nfd^'}$]
h.PY$W<
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ _TH'v:C
{jbOcx$t
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ k9a-\UIMet
(xMAo;s_
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© Bp9
u6R
bj
bm"~
ÃâÒßѧרҵ£º 5'6Oan7dL:
2: fSn&*/>
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ znD0&CS9q
21W>}I"0?
Ïû»¯ÄÚ¿Æ£º 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ 0&zp9(G5
ho 4~-xmN
ѪҺ²¡Ñ§×¨Òµ£º 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿ ^dRB(E}|)
kz] qk15w
Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ (רҵ»ù´¡: ÃâÒßѧ) %vgn>A?]1
aR+vY1d"
Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö) p%8y!^g
*IfLoKS'
1. ADCC(antibody dependent cell-mediated cytotoxicity) <\Lii0hi!
|}=xA%)
2. »·æß¾úËØ(cyclosporin) .*i.Z
/aNlr>^
3. KIR(killer cell inhibitory receptor) fn;`V it#
_I+QInD ;)
4. HLDA(human leucocyte differentiation antigen) AfB,`l`k
AKu]c-
5. Interleukin 18(IL-18) =wtu
Gg$4O 8
6. ÕûºÏËØ(integrin) D.su^m_1
]?M3X_Mq
7. Fas/FasL \AQ*T`Dq
5LM Ay"
8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå) jI[Y< (F ;
E9<oA.
9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM) {Dup k0'(
eaB6e@]@
10. Th1/Th2 n%X5TJE
';'gKX!9V
11. »ùÒòÒßÃç(DNAÒßÃç) )jm!bR`
-Ph"#R&
12. chemokines and chemokine receptor YMXhzqj
B:oE&Ahh{
13. ÃâÒßÄÍÊÜ %1h%#/
#[
t.X8
c/,;g
14. ¹²´Ì¼¤·Ö×Ó Op<,e{[]
e>J.r("f
15. ËÀÍö½á¹¹Óò(death domain) Z@(m.&ZRx
7fE U5@
¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö) GBSuTu8
yVfF
*nG
1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬? }-/oL+j
H'a6]
]2
2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦ÓᣠY+)qb);
L
NS O]\
£¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î hik.c3
!(A<
£¨2£©1977Ä꣺·ÅÉäÃâÒß·¨ JO-FnoQK
%1\~OnT
£¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå tZ>'tE
s.$:.*
k
£¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹ 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£ <I 0 EjV
O%s7 }bR3
Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ) ÎÊ´ðÌâ(ÿÌâ25·Ö) 'r'+$D7
|
\FJ
1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£ @Ta0v:Y
\ lW*.<
2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿ `D $ "K1u
QCJf
3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£ 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£